P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 4, 1996, Pages 491-497

  Wittenburg, Henning ^a   Bültmann, Ralph ^a   Pause, Birgit ^a,c   Ganter, Claudia ^b   Kurz, Gerhart ^b   Starke, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Institut fur Biochemie I   (Germany)

Author keywords

Ecto nucleotidase; Evans blue; Guinea pig taenia coli; P(2X) purinoceptor; P(2Y) purinoceptor; P2 purinoceptor antagonists; Rat vas deferens; Trypan blue

Indexed keywords

ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CARBACHOL; EVANS BLUE; NUCLEOTIDASE; PURINE P2 RECEPTOR; RECEPTOR SUBTYPE; TRYPAN BLUE; ADENOSINE 5'-O-(2-THIODIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; DRUG DERIVATIVE; ECTOATPASE; NUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; COLON TENIA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GUINEA PIG; IN VITRO STUDY; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; VAS DEFERENS; VASOCONSTRICTION; ANIMAL; COLON; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MUSCLE CONTRACTION; MUSCLE RELAXATION; SMOOTH MUSCLE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; COLON; EVANS BLUE; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; RATS; RECEPTORS, PURINERGIC P2; STRUCTURE-ACTIVITY RELATIONSHIP; THIONUCLEOTIDES; TRYPAN BLUE; VAS DEFERENS;

EID: 0029658871     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00168441     Document Type: Article

References (16)

1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58
2. 2x-purinoceptors in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348:684-687
3. 2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349:74-80
4. 2x-purinoceptors in rat vas deferens. Br J Pharmacol 112:690-694
5. 2Y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase. Naunyn-Schmiedeberg's Arch Pharmacol 352:477-482
6. 2x-purinoceptors in rat vas deferens. Br J Pharmacol 113:349-354
7. Bültmann R, Driessen B, Gonçalves J, Starke K (1995) Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue. Naunyn-Schmiedeberg's Arch Pharmacol 351:555-560
8. 2-purinoceptors in guinea-pig taenia coli. Naunyn-Schmiedeberg's Arch Pharmacol 353:445-451
9. 2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates. Naunyn-Schmiedeberg's Arch Pharmacol 354:481-490
10. 2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin. Naunyn-Schmiedeberg's Arch Pharmacol 354:498-504
11. 2-purinoceptors in guinea-pig taenia coli. Naunyn-Schmiedeberg's Arch Pharmacol 351:107-110
12. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 283-335
13. 2x purinoceptors in rat vas deferens. Eur J Pharmacol 263:301-309
14. 2x purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens. Br J Pharmacol 115:177-185
15. Motulsky HJ, Ransnas LA (1987) Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J 1:365-374
16. Waud DR (1976) Analysis of dose-response relationships. In: Narahashi T, Bianchi CP (eds) Advances in general and cellular pharmacology, vol 1. Plenum, New York London, pp 145-178